期刊文献+

趋化因子CXCL17在胃癌组织中的表达及其临床相关性研究 被引量:3

Expression of chemokine CXCL17 and its clinical relevance in gastric carcinoma
下载PDF
导出
摘要 目的:分析趋化因子CXCL17在胃癌及癌旁正常组织的表达及分布情况,并探讨其差异表达的临床意义。方法:分别采用实时荧光定量PCR和免疫组化对40例术后切除的胃癌及相应癌旁正常胃组织CXCL17的表达及分布情况进行检测。通过临床病理分析及Kaplan-Meier生存曲线的分析,明确CXCL17在胃癌组织中的表达情况及其临床意义。结果:CXCL17蛋白和mRNA的表达在胃癌组织较癌旁正常组织明显降低(P<0.05)。临床病理数据分析显示,CXCL17表达的下调与胃癌分化程度有关(P<0.01),与病人性别、年龄、淋巴结转移、原发部位肿瘤大小、肿瘤分期、癌胚抗原表达水平等未见明显相关性。Kaplan-Meier生存分析显示,CXCL17高表达组相对低表达组有明显的生存延长(P<0.05)。结论:CXCL17可作为胃癌预后的关键因素之一参与胃癌的发生发展。 AIM: To investigate the expression and distribution of chemokine CXCL17 in gastric cancer and its clinical significance. METHODS: The CXCL17 expression was detected by real-time PCR and immunohistochemistry. The correlation between the CXCL17 expression and clinicopathological features was statistically analyzed and Kaplan-Meier survival analysis was used to evaluate the prognosis. RESULTS: A lower expression levels of CXCL17 were observed in the tumor tissues compared with the paired normal tissues( P〈0. 05). Down-regulation of CXCL17 was associated with the degree of tumor differentiation and the size of tumor at primary site( P〈0. 05). Kaplan-Meier survival analysis showed that increased CXCL17 in the tumor tissues was associated with longer survival time. CONCLUSION: The result might illustrate that CXCL17 acts as a key factor in the prognosis of gastric cancer and is closely associated with the progression of gastric cancer.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2016年第6期1022-1026,共5页 Chinese Journal of Pathophysiology
基金 浙江省自然科学基金青年项目(No.LQ16H190003) 温州市科技计划项目(No.Y20140216 No.Y20140308) 浙江省大学生科技创新活动计划(新苗人才计划)资助项目(No.2015R413004)
关键词 胃癌 趋化因子CXCL17 生存分析 Gastric cancer Chemokine CXCL17 Survival analysis
  • 相关文献

参考文献11

  • 1邹文斌,李兆申.中国胃癌发病率及死亡率研究进展[J].中国实用内科杂志,2014,34(4):408-415. 被引量:436
  • 2Archie V , K a u h J , Jones D V Jr, et al. Gastric cancer:standards for the 21st century [J]. Cat Rev Oncol H e m a tol, 2006, 57(2) :123-131. 被引量:1
  • 3曹晓雪,宋光.胃癌的肿瘤微环境研究进展[J].现代生物医学进展,2014,14(31):6177-6179. 被引量:8
  • 4Strieter R M , Belperio J A ,P h i i p s R J ,et al. C X C c h e m o -kines in angiogenesis of cancer [J]. Semin Cancer Biol,2004, 14(3) :195-200. 被引量:1
  • 5Weinstein E J ,H e a d R ,G i ggs D W ,et al. V C C -1,a novelchemokine,promotes tumor growth [J]. B i o c h e m B i o -phys Res C o m m u n ,2006,350(1) :74-81. 被引量:1
  • 6B u r k h a r d t A M, Tai K P , Flores-Guiterrez J P, et al.C X C L 17 is a mucosal chemokine elevated in idiopatiiicpulmona/ filDrosis that exhibit/ broad antimicrobial activity[J]. J I m m u n o l,2012, 188(12) :6399-6406. 被引量:1
  • 7Lee W Y ,W a n g C J ,Lin T Y ,et al. C X C L 17,an orphanchemokine,acts as a novel angiogenic and anti-inflammato factor [J]. A m J Physiol Endocrinol M e t a b, 2013,304(1) :E 32-E 40. 被引量:1
  • 8Lin K ,Zou R , Lin F ,et al. Expression and effect ofC X C L 14 in colorectal carcinoma [J]. Mol M e d R e p ,2014, 10(3) :1561-1568. 被引量:1
  • 9Hiraoka N ,Yamazaki-Itoh R ,Ino Y ,et al. C X C L 17 andI C A M 2 are associated with a potential anti-tumor i m m u n eresponse in early intraepithelial stages of h u m a n pancreaticcarcinogenesis [J]. Gastroenterolog, 2011,140 ( 1 ):310-321. 被引量:1
  • 10Li L , Y a n J, X u J ,et al. C X C L 17 expression predictspoor prognosis and correlates with adverse i m m u n e infiltrationin hepatocellular carcinoma[J]. PLo S O n e ,2014,9(10) :e110064. 被引量:1

二级参考文献103

共引文献441

同被引文献22

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部